Evidence map›Paper›PMID 34071629›Full record

ReviewMolecules (Basel, Switzerland)2021

Advances in Pyranopyrazole Scaffolds' Syntheses Using Sustainable Catalysts-A Review.

Ravi Kumar Ganta, Nagaraju Kerru, Suresh Maddila, Sreekantha B Jonnalagadda

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Synthesis ofAnnals of medicine · 2022
    Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Ravi Kumar GantaDepartment of Chemistry, GITAM Institute of Sciences, GITAM University, Visakhapatnam 530045, India.
Nagaraju KerruDepartment of Chemistry, GITAM School of Science, GITAM University, Bengaluru Campus, Karnataka 561203, India.ORCID 0000-0002-5354-9545
Suresh MaddilaDepartment of Chemistry, GITAM Institute of Sciences, GITAM University, Visakhapatnam 530045, India.
Sreekantha B JonnalagaddaSchool of Chemistry & Physics, Westville Campus, University of KwaZulu-Natal, Chiltern Hills, Durban 4000, South Africa.ORCID 0000-0001-6501-8875
GITAM University · INUniversity of KwaZulu-Natal · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Heterogeneous catalysis plays a crucial role in many chemical processes, including advanced organic preparations and the design and synthesis of new organic moieties. Efficient and sustainable catalysts are vital to ecological and fiscal viability. This is why green multicomponent reaction (MCR) approaches have gained prominence. Owing to a broad range of pharmacological applications, pyranopyrazole syntheses (through the one-pot strategy, employing sustainable heterogeneous catalysts) have received immense attention. This review aimed to emphasise recent developments in synthesising nitrogen-based fused heterocyclic ring frameworks, exploring diverse recyclable catalysts. The article focused on the synthetic protocols used between 2010 and 2020 using different single, bi- and tri-metallic materials and nanocomposites as reusable catalysts. This review designated the catalysts' efficacy and activity in product yields, reaction time, and reusability. The MCR green methodologies (in conjunction with recyclable catalyst materials) proved eco-friendly and ideal, with a broad scope that could feasibly lead to advancements in organic synthesis.

Indexed as

green protocolsheterogeneous catalystsmulticomponent reactionsone-pot processpyranopyrazoles

Identifiers

PMID34071629
PMCPMC8199150
OpenAlexW3164320288

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.